Project P-0229

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameProject P-0229
Drug Alias NamePhospholipase A2 inhibitors (Yissum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsHypersensitivityPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYissum Research Development Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYissum Research Development Company
Active IndicationsN/A
Inactive IndicationsHypersensitivityPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A